
Work Here?
Vironix AI offers a virtual care platform for healthcare providers to remotely monitor patients with chronic diseases using RPM, RTM, CCM, PCM, CCCM and a staff monitoring service. The system collects home health data and uses validated algorithms and proprietary scores to risk-stratify patients, directing care where needed, with an automated CMS claims workflow to speed reimbursement. It differentiates itself by offering the full suite of chronic care programs plus risk stratification and outsourcing of monitoring staff. The goal is to improve patient outcomes through at-home monitoring and timely interventions while helping providers extend care and secure reimbursement.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$280K
Headquarters
New York City, New York
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$280k
Below
Industry Average
Funded Over
1 Rounds
Industry standards
Health Insurance
Stock Options
Remote Work Options
Hybrid Work Options
Vironix Health celebrates the launch of the Remote Monitoring Leadership Council, a new alliance of digital health CEOs united to advance tech-enabled care and champion the expansion of Remote Patient Monitoring (RPM) across the country.
The collaboration comes a year after Vironix announced its partnership with Oxford University to develop novel prediction methods for proactive intervention in congestive heart failure.
AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- Vironix Health Inc., an innovative leader in AI-powered remote patient monitoring applications for healthcare providers, is bolstering its alliance with the University of Oxford's Mathematical Institute. The collaboration aims squarely at advanced prediction of Chronic Kidney Disease (CKD) progression.Oxford UniversityBuilding on the triumph of last year's synthetic patient data generation project, the partners are setting their sights on CKD, a medical challenge marked by gradual kidney function deterioration. Early interventions leveraging AI can amplify patient well-being, decelerate the disease progression, and reduce healthcare costs. Dr. Sumanth Swaminathan, CEO of Vironix Health, commented on the partnership's potential, remarking, "Vironix is committed to innovating preventive care technologies that prioritize validation through scientific rigor and peer review
Vironix Health, a digital health company, has announced the appointment of Mahesh Visvanathan, MS/MBA as Chief Operations and Business Development Officer to lead its strategic partnership and commercialization strategy.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$280K
Headquarters
New York City, New York
Founded
2020
Find jobs on Simplify and start your career today